Illumina has a long history of driving advancements in genomics, providing the tools and technologies that have ...

GRAIL faces financial challenges but holds significant growth potential with its Galleri cancer-screening test. Click here to ...

Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, ...

Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the ...

BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...

The Dutch competition watchdog is seeking beefed-up powers to probe more small deals that risk crushing competition in ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

Her scheme of enlisting foreign governments to stop U.S. mergers suffered a blow Tuesday when Europe’s high court ruled that regulators in Brussels exceeded their authority by blocking Illumina ...

launching new products and services, and introducing ambitious earnings guidance for 2024. Overall ILMN ranks 9th on our list ...

Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of ...

(RTTNews) - Illumina, Inc. (ILMN) Tuesday announced that the 432 million euros fine imposed by the European Commission over GRAIL deal is no longer be payable after favorable verdict by the ...